Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Articles by Jeffrey, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Right arrow Articles by Jeffrey, A. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Thresholds for the Effects of 2-Acetylaminofluorene in Rat Liver

Gary M. Williams

New York Medical College, Department of Pathology, Valhalla, New York 10595, USA, gary_williams{at}nymc.edu

Michael J. Iatropoulos

New York Medical College, Department of Pathology, Valhalla, New York 10595, USA

Alan M. Jeffrey

New York Medical College, Department of Pathology, Valhalla, New York 10595, USA

To explore for practical thresholds for DNA-reactive carcinogens in rat liver carcinogenicity, we have conducted a series of exposure-response studies using 2 well-studied hepatocarcinogens, 2-acetylaminofluorene (AAF) and diethylnitrosamine (DEN). Findings with AAF, including as yet unpublished experiments, are reviewed here and related to DEN observations. In these studies, we have administered exact intragastric doses during an initiation segment (IS) of 12—16 weeks followed in some experiments by phenobarbital (PB) as a liver tumor promoter for 24 weeks to enhance manifestation of initiation. The cumulative doses (CD) of AAF at the end of ISs ranged from 0.094 to 282.2 mg/kg. Our findings for AAF in the IS can be summarized as follows: (1) the earliest parameter to be affected with administration of low doses was the appearance of DNA adducts (around 4 weeks), followed at higher doses by cell proliferation; (2) formation of DNA adducts was nonlinear, with a no-observed effect level (NOEL) at a CD of 0.094 mg/kg and a plateau at higher doses (94.1 mg/kg); (3) cytotoxicity (necrosis) showed a NOEL at a CD of 28.2 mg/kg; (4) compensatory hepatocellular proliferation showed a NOEL at a CD of 28.2 mg/kg and was supralinear at a high CD (282.2 mg/kg); (5) formation of preneoplastic hepatocellular altered foci (HAF) showed a NOEL at a CD of 28.2 mg/kg, and was supralinear at a high CD (282.2 mg/kg); (6) a NOEL (CD 28.2 mg/kg) was found for tumor development and the exposure—response was supralinear. We interpret these findings to reflect practical thresholds for hepatocellular initiating effects of AAF and exaggerated responses at high-exposures doses, as also found for DEN. Thus, mechanisms of carcinogenesis can differ between low and high doses.

Key Words: 2-Acetylaminofluorene • carcinogen • DNA adducts • hepatocyte proliferation • liver • no-observed effect level • preneoplastic hepatocellular altered foci • threshold.

References

  • Chen, B., Liu, L., Castonguay, A., Maronpot, R.R., Anderson, M.W., and You, M.L. (1993). Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone induced mouse lung tumors. Carcinogenesis 14, 1603— 8.[Abstract/Free Full Text]
  • Cohen, S.M., and Ellwein, L.B. (1990). Cell proliferation in carcinogenesis. Science 249, 1007—11.[Abstract/Free Full Text]
  • Counts, J.L., and Goodman, J.I. (1995). Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. Reg Toxicol Pharmacol 21, 418—21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Den Otter, W., Koten, J.W., Van Der Vegt, B.J.H., Beemer, F.A., Boxma, O.J., Derkinderen, D.J., De Graaf, P.W., Hiber, J., Lips, C.J.M., Roholl, P.M.L., Sluijter, F.J.H., Tan, K.E.W.P., Van Der Heyden, K.A., Van Der Ven, L., and Van Unnik, J.A.M. (1990). Oncogenesis by mutations in anti-oncogenes: a view. Anticancer Res 10, 475—88.[Web of Science][Medline] [Order article via Infotrieve]
  • Dietrich, D. (1993). Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA) a novel endogenous marker for cell proliferation. Crit Rev Toxicol 23, 77—109.[Web of Science][Medline] [Order article via Infotrieve]
  • Enzmann, H., Zerban, H., Kopp-Schneider, A., Löser, A., and Bannasch, P. (1995). Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis 16, 1513— 18.[Abstract/Free Full Text]
  • Farmer, J.H., Kodell, R.L., Greenman, D.L., and Shaw, G.W. (1980). Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J Environ Pathol Toxicol 3(3), 55—68.[Web of Science][Medline] [Order article via Infotrieve]
  • Fukushima, S. (1999). Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment. Cancer Lett 143, 157—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gaylor, D.W. (1980). The ED01 study: summary and conclusions. J Environ Pathol Toxicol 3(3), 179—83.[Web of Science][Medline] [Order article via Infotrieve]
  • Gebhardt, R., Tanaka, T., and Williams, G.M. (1989). Glutamine synthetase heterogenous expression as a marker for the cellular lineage of preneoplastic and neoplastic liver populations. Carcinogenesis 10, 1917—23.[Abstract/Free Full Text]
  • Gebhardt, R., and Williams, G.M. (1995). Glutamine synthetase and hepatocarcinogenesis. Carcinogenesis 16, 1673—81.[Free Full Text]
  • Gupta, R.C. (1985). Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res 45, 5656—662.[Abstract/Free Full Text]
  • Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hengstler, J.G., Bogdanfly, M.S., Bolf, H.M., and Oesch, F. (2003). Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu Rev Pharmacol Toxicol 43, 485—520.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hino, O., and Kitagawa, T. (1981). Existence of a practical threshold dose for the hepatocarcinogen 3'-methyl-4-(dimethylamino)azobenzene in rat liver. Gann 72, 637—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Hussain, S.P., and Harris, C.C. (1998). Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58, 4023—37.[Free Full Text]
  • Iatropoulos, M.J., Jeffrey, A.M., Enzmann, H.E., von Kentz, E., Schlueter, G., and Williams, G.M. (2001). Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic. Exp Toxicol Pathol 53, 345—57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Keegan, T.E., Simmons, J.E., and Pegram, R.A. (1998). NOAEL and LOAEL determinations of acute hepatotoxicity for chloroform and bromodichloromethane delivered in an aqueous vehicle to F344 rats. J Toxicol Environ Health 55, 65—75.[CrossRef][Web of Science]
  • Manam, S., Shinder, G.A., Joslyn, D.J., Kraynak, A.R., Hammermeister, C.L., Leander, K.R., Ledwith, D.J., Prahalada, S., van Zwieten, M.J., and Nichols, W.W. (1995). Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouselivertumors. Carcinogenesis 16, 1113—9.[Abstract/Free Full Text]
  • Miller, J.A. (1994). Sulfonation in chemical carcinogenesis-history and present status. Chem-Biol Interact 92, 329—41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • National Research Council (NRC). (1977). Safe Drinking Water and Health. National Academy of Sciences, Washington, DC.
  • Nestmann, E.R., Bryant, D.W., Carr, J., Fennell, T.T., Gallagher, J.E., Gorelick, N.J., Swenberg, J.A., and Williams, G.M. (1996). Toxicological significance of DNA adducts. Report of an expert panel. Reg Toxicol Pharmacol 140, 254—63.
  • Neumann, H.-G. (1986). The role of DNA damage in chemical carcinogenesis of aromatic amines. J Cancer Res Clin Oncol 112, 100—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Page, N.P., Singh, D.V., Farland, W., Goodman, J.I., Conolly, R.B., Anderson, M.E., Clewell, H.J., Frederick, C.B., Yamasaki, H., and Lucier, G. (1997). Implementation of EPA revised cancer assessment guidelines: incorporation of mechanistic and pharmacokinetic data. Fundam Appl Toxicol 37, 16—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Peto, R., Gray, R., Branton, P., and Grasso, P. (1991a). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res 51, 6415—51.[Abstract/Free Full Text]
  • Peto, R., Gray, R., Branton, P., and Grasso, P. (1991b). Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res 51, 6452—69.[Abstract/Free Full Text]
  • Poirier, M.C., and Connor, R.J. (1982). Radioimmunoassay for 2-acetylaminofluorene-DNA adducts. Meth Enzymol 84, 607—18.[Web of Science][Medline] [Order article via Infotrieve]
  • Randerath, K., and Randerath, E. (1994). 32P-postlabeling methods for DNA adduct detection: overview and critical evaluation. Drug Metab Rev 26, 67—85.[Web of Science][Medline] [Order article via Infotrieve]
  • Reddy, M.V., and Randerath, K. (1986). Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543—51.[Abstract/Free Full Text]
  • Ringer, D.R., and Norton, T.R. (1987). Further characterization of the ability of hepatocarcinogens to lower rat liver arylsulfotransferase activity. Carcinogenesis 8, 1749—52.[Abstract/Free Full Text]
  • Root, M., Lange, T., and Campbell, T.C. (1997). Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver. Chemico-Biolog Interact 106, 213—27.[CrossRef]
  • Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Tatematsu, M., and Ito, N. (1984). The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. GANN 75, 199— 202.[Web of Science][Medline] [Order article via Infotrieve]
  • Swenberg, J.A., La, D.K., Scheller, N.A., and Wu, K.-Y. (1995). Dose-response relationships for carcinogens. Toxicol Lett 82/83, 751—6.[CrossRef]
  • Tong, C., Fazio, M., and Williams, G.M. (1980). Cell cycle-specific mutagenesis at the hypoxanthine phosphoribosyl-transferase locus in adult rat live epithelial cells. Proc Natl Acad Sci USA 77, 7377—9.[Abstract/Free Full Text]
  • Umemura, T., Tokumo, K., Sirma, H., Gebhardt, R., Poirier, M.C., and Williams, G.M. (1993). Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett 73, 1—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Verna, L., Whysner, J., and Williams, G.M. (1996a). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Therap 71, 57—82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Verna, L., Whysner, J., and Williams, G.M. (1996b). 2-acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. Pharmacol Therap 71, 83—106.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Waddell, W.J. (2003a). Thresholds in chemical carcinogenesis: what are animal experiments telling us? Toxicol Pathol 31, 260—2.[Abstract/Free Full Text]
  • Waddell, W.J. (2003b). Thresholds of carcinogenicity in the EDO1 study. Toxicol Sci 72, 158—63.[Abstract/Free Full Text]
  • Watanabe, L., and Williams, G.M. (1978). Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J Natl Cancer Inst 61, 1311—4.[Web of Science][Medline] [Order article via Infotrieve]
  • Whysner, J., Wang, C., Zang, E., Iatropoulos, M.J., and Williams, G.M. (1994). Dose response of promotion by butylated hydroxyanisole in chemically initiated tumours of the rat forestomach. Food Chem Toxicol 32, 215—22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M. (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochem Biophys Acta 605, 167—89.[Medline] [Order article via Infotrieve]
  • Williams, G.M. (1986). Epigenetic promoting effects of butylated hydroxyanisole. Food Chem Toxicol 24, 1163—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M. (1997). Chemicals with carcinogenic activity in the rodent liver; mechanistic evaluation of human risk. Cancer Lett 118, 1—14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M. (1999a). Chemically induced rodent preneoplastic lesions as indicators of carcinogenic activity. In The Use of Short-and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation (D. B. McGregor, J. M. Rice, and S. Venitt, eds.), pp. 185—202. IARC Scientific Publications No. 146. Lyon, France.
  • Williams, G.M. (1999b). Mechanistic considerations in cancer risk assessment. Inhal Toxicol 11, 549—54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M., and Iatropoulos, M.J. (2002). Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol Pathol 30, 41—53.[Abstract/Free Full Text]
  • Williams, G.M., Gebhardt, R., Sirma, H., and Stenbäck, F. (1993). Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis 14, 2149—56.[Abstract/Free Full Text]
  • Williams, G.M., Iatropoulos, M.J., and Jeffrey, A.M. (2000). Mechanistic basis for nonlinearities and thresholds in rat liver carcinogens by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 28, 388—95.[Abstract/Free Full Text]
  • Williams, G.M., Iatropoulos, M.J., Jeffrey, A.M., Luo, F.-Q., and Wang, C.-X. (1998a). Diethylnitrosamine exposure-rsponses for DNA ethylation, hepatocellular proliferation and initiation of carcinogenesis in rat liver display non-linearities and thresholds. Arch Toxicol 73, 394—402.[CrossRef][Web of Science]
  • Williams, G.M., Iatropoulos, M.J., Wang, C.X., Ali, N., Rivenson, A., Peterson, L.A., Schulz, C., and Gebhardt, R. (1996). Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit some non-linearities. Carcinogenesis 17, 2253—8.[Abstract/Free Full Text]
  • Williams, G.M., Iatropoulos, M.J., Wang, C.-X., Jeffrey, A.M., Thompson, S., Pittman, B., Palasch, M., and Gebhardt, R. (1998b). Non-linearities in 2-acetylaminofluorene exposure-responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Toxicol Sci 45, 152—61.[Abstract/Free Full Text]
  • Williams, G.M., Iatropoulos, M.J., and Whysner, J. (1999). Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives. Food Chem Toxicol 37, 1027—38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M., Tanaka, T., Maruyama, H., Maeura, Y., Weisburger, J.H., and Zang, E. (1991). Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-acetylaminofluorene. Cancer Res 51, 6224—30.[Abstract/Free Full Text]
  • Williams, G.M., and Watanabe, K. (1978). Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion of persistence following removal of carcinogen. J Natl Cancer Instit 61, 113—121.[Web of Science][Medline] [Order article via Infotrieve]
  • Williams, G.M., and Whysner, J. (1995). Mechanistic considerations in risk assessment for epigenetic tumor-promoting carcinogens. In Growth Factors and Tumor Promotion: Implications for Risk Assessment (R. M. McClain, T. J. Slaga, R. LeBoeuf and H. Pitot, eds.), pp. 369—383. John Wiley and Sons, Inc., New York.
  • Williams, G.M., and Whysner, J. (1996). Epigenetic carcinogens: evaluation and risk assessment. Exp Toxicol Pathol 48, 189—95.[Web of Science][Medline] [Order article via Infotrieve]
  • Wiltse, J., and Dellarco, V.L. (1996). U.S. Environmental Protection Agency guidelines for carcinogen risk assessment: Past and future. Mutat Res, 365, 3—15.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 2 suppl, 85-91 (2004)
DOI: 10.1080/01926230490451716
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
A. R. Boobis, S. M. Cohen, N. G. Doerrer, S. M. Galloway, P. J. Haley, G. C. Hard, F. G. Hess, J. S. Macdonald, S. Thibault, D. C. Wolf, et al.
A Data-Based Assessment of Alternative Strategies for Identification of Potential Human Cancer Hazards
Toxicol Pathol, October 1, 2009; 37(6): 714 - 732.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Fukushima, A. Kinoshita, R. Puatanachokchai, M. Kushida, H. Wanibuchi, and K. Morimura
Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens
Carcinogenesis, November 1, 2005; 26(11): 1835 - 1845.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Articles by Jeffrey, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Right arrow Articles by Jeffrey, A. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?